Page last updated: 2024-12-05

hexahydrofarnesylacetone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hexahydrofarnesylacetone: a C-18 terpene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10408
CHEBI ID145744
SCHEMBL ID716506
MeSH IDM0063206

Synonyms (37)

Synonym
6,10,14-trimethylpentadecan-2-one
6,10,14-trimethyl-2-pentadecanone
hexahydrofarnesylacetone
einecs 207-950-7
2-pentadecanone, 6,10,14-trimethyl-
hexahydrofarnesyl acetone
phytone
CHEBI:145744
502-69-2
AKOS001727037
STK761211
(r,r)-phytone
phytol ketone
fitone
FT-0632240
AKOS016347358
6,10,14-trimethyl pentadecan-2-one
6,10,14-trimethyl-2-pentadecanon
6,10,14-trimethyl-pentadecane-2-one
SCHEMBL716506
mfcd00065420
perhydrofarnesyl acetone
W-109084
sr-01000526355
SR-01000526355-1
6,10,14-trimethyl-pentadecan-2-one
DTXSID40862063
SY249550
Q67880075
(+/-)-phytone; 6,10,14-trimethylpentadecan-2-one; hexahydrofarnesyl acetone
AC6244
()-phytone; 6,10,14-trimethylpentadecan-2-one; hexahydrofarnesyl acetone
AS-78022
CS-0023161
HY-N3074
(+)-phytone
(+/-)-phytone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ketoneA compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's1 (6.25)18.2507
2000's3 (18.75)29.6817
2010's11 (68.75)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.56 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]